{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-018503","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2023-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.980334+00:00","generated_at":"2026-06-19T18:05:00.148089+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Avenue Therapeutics amends bylaws, removes InvaGen special rights, changes quorum","bullets":["Board adopted Second Amended and Restated Bylaws effective February 9, 2023.","Removed all special rights and provisions previously granted to InvaGen Pharmaceuticals Inc.","Quorum for stockholder meetings changed to majority of outstanding voting power.","No immediate financial or operational impact disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-018503","json":"https://secwatch.observer/filing/0001104659-23-018503.json","markdown":"https://secwatch.observer/filing/0001104659-23-018503.md","text":"https://secwatch.observer/filing/0001104659-23-018503.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000110465923018503/0001104659-23-018503-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000110465923018503/tm236264d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T18:05:00.148089+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"064cd310cc40518ced69b0d63b5125a59a0f1f03","claim":"AVENUE THERAPEUTICS, INC.: Removed special rights provisions for InvaGen Pharmaceuticals and changed stockholder meeting quorum requirement to majority of outstanding voting power (effective 2023-02-09).","evidence_excerpt":"On February 9, 2023, the Board of Directors (the “Board”) of Avenue Therapeutics, Inc. (the “Company”) adopted the Second Amended and Restated Bylaws of the Company (the “Amended Bylaws”), effective immediately.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465923018503/0001104659-23-018503-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-02-09"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}